Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells (Q40572659)

21 September 2017

Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells (English)

1 reference

21 September 2017

0 references

1

1 reference

21 September 2017

Yueh-Chiang Hu

2

1 reference

21 September 2017

Huei-Ju Ting

series ordinal

3

1 reference

21 September 2017

Yi-Fen Lee

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

3350-3360

1 reference

21 September 2017

19

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207461

21 September 2017

0 references

cites work

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

E2F activity is biphasically regulated by androgens in LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Vitamin D: a modulator of cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Androgen receptor expression in androgen-independent prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Analysis with flow cytometry of green fluorescent protein expression in leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207461

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207461

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference